Prevalence of sarcopenia among patients with hepatocellular carcinoma: A systematic review and meta‑analysis
- Authors:
- Jiye Liu
- Hanyong Luo
- Letian Huang
- Jiahe Wang
-
Affiliations: Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China, Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China - Published online on: May 18, 2023 https://doi.org/10.3892/ol.2023.13869
- Article Number: 283
-
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Hartke J, Johnson M and Ghabril M: The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 34:153–159. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA and Soerjomataram I: Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 77:1598–1606. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Li C and He WQ: Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory. Liver Int. 42:2299–2316. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Clark T, Maximin S, Meier J, Pokharel S and Bhargava P: Hepatocellular carcinoma: Review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol. 44:479–486. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Villanueva A: Hepatocellular carcinoma. N Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chang KV, Chen JD, Wu WT, Huang KC, Hsu CT and Han DS: Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: A systematic review and meta-analysis. Liver Cancer. 7:90–103. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Papadopoulou SK: Sarcopenia: A contemporary health problem among older adult populations. Nutrients. 12:12932020. View Article : Google Scholar : PubMed/NCBI | |
|
Rier HN, Jager A, Sleijfer S, Maier AB and Levin MD: The prevalence and prognostic value of low muscle mass in cancer patients: A review of the literature. Oncologist. 21:1396–1409. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gibson DJ, Burden ST, Strauss BJ, Todd C and Lal S: The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: A systematic review. Eur J Clin Nutr. 69:1079–1086. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shachar SS, Williams GR, Muss HB and Nishijima TF: Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer. 57:58–67. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P and Stewart LA; PRISMA-P Group, : Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 4:12015. View Article : Google Scholar : PubMed/NCBI | |
|
Lo CK, Mertz D and Loeb M: Newcastle-Ottawa Scale: Comparing reviewers' to authors' assessments. BMC Med Res Methodol. 14:452014. View Article : Google Scholar : PubMed/NCBI | |
|
Borenstein M, Hedges LV, Higgins JP and Rothstein HR: A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 1:97–111. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Duval S and Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 56:455–463. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Alsebaey A, Sabry A, Rashed HS, Elsabaawy MM, Ragab A, Aly RA and Badran H: MELD-sarcopenia is better than ALBI and MELD score in patients with hepatocellular carcinoma awaiting liver transplantation. Asian Pac J Cancer Prev. 22:2005–2009. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Akce M, Liu Y, Zakka KM, Martini DJ, Draper A, Alese OB, Shaib WL, Wu C, Wedd J, Sellers MT, et al: The impact of inflammatory biomarkers, BMI, and sarcopenia on survival in advanced hepatocellular carcinoma treated with immunotherapy. J Clin Oncol. 38 (4 Suppl):S5532020. View Article : Google Scholar | |
|
Begini P, Gigante E, Antonelli G, Carbonetti F, Iannicelli E, Anania G, Imperatrice B, Pellicelli AM, Fave GD and Marignani M: Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis. Ann Hepatol. 16:107–114. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dong D, Shi JY, Shang X, Liu B, Xu WL, Cui GZ and Wang NY: Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis. Medicine (Baltimore). 101:e286802022. View Article : Google Scholar : PubMed/NCBI | |
|
Guichet PL, Taslakian B, Zhan C, Aaltonen E, Farquharson S, Hickey R, Horn CJ and Gross JS: MRI-derived sarcopenia associated with increased mortality following yttrium-90 radioembolization of hepatocellular carcinoma. Cardiovasc Intervent Radiol. 44:1561–1569. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ha Y, Kim D, Han S, Chon YE, Lee YB, Kim MN, Lee JH, Park H, Rim KS and Hwang SG: Sarcopenia predicts prognosis in patients with newly diagnosed hepatocellular carcinoma, independent of tumor stage and liver function. Cancer Res Treat. 50:843–851. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hirota K, Kawaguchi T, Koya S, Nagamatsu A, Tomita M, Hashida R, Nakano D, Niizeki T, Matsuse H, Shiba N and Torimura T: Clinical utility of the liver frailty index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma. Hepatol Res. 50:330–341. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Imai K, Takai K, Watanabe S, Hanai T, Suetsugu A, Shiraki M and Shimizu M: Sarcopenia impairs prognosis of patients with hepatocellular carcinoma: The role of liver functional reserve and tumor-related factors in loss of skeletal muscle volume. Nutrients. 9:10542017. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YR, Park S, Han S, Ahn JH, Kim S, Sinn DH, Jeong WK, Ko JS, Gwak MS and Kim GS: Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Sci Rep. 8:71572018. View Article : Google Scholar : PubMed/NCBI | |
|
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, Kamo N, Yagi S, Taura K, Okajima H and Uemoto S: Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg. 269:924–931. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kobayashi T, Kawai H, Nakano O, Abe S, Kamimura H, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S and Terai S: Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer. 18:7562018. View Article : Google Scholar : PubMed/NCBI | |
|
Kotoh Y, Saeki I, Yamasaki T, Sasaki R, Tanabe N, Oono T, Matsuda T, Hisanaga T, Matsumoto T, Hidaka I, et al: Effect of handgrip strength on clinical outcomes of patients with hepatocellular carcinoma treated with lenvatinib. Appl Sci. 10:54032020. View Article : Google Scholar | |
|
Kroh A, Uschner D, Lodewick T, Eickhoff RM, Schöning W, Ulmer FT, Neumann UP and Binnebösel M: Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients. Hepatobiliary Pancreat Dis Int. 18:28–37. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lanza E, Masetti C, Messana G, Muglia R, Pugliese N, Ceriani R, Lleo de Nalda A, Rimassa L, Torzilli G, Poretti D, et al: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma. PLoS One. 15:e02323712020. View Article : Google Scholar : PubMed/NCBI | |
|
Lee J, Cho Y, Park S, Kim JW and Lee IJ: Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with radiotherapy. Front Oncol. 9:10752019. View Article : Google Scholar : PubMed/NCBI | |
|
Levolger S, van Vledder MG, Muslem R, Koek M, Niessen WJ, de Man RA, de Bruin RW and Ijzermans JN: Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. J Surg Oncol. 112:208–213. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liao C, Li G, Bai Y, Zhou S, Huang L, Yan M, Qiu F, Chen J, Wang Y, Tian Y and Chen S: Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomograms. J Gastrointest Oncol. 12:669–693. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Meister FA, Lurje G, Verhoeven S, Wiltberger G, Heij L, Liu WJ, Jiang D, Bruners P, Lang SA, Ulmer TF, et al: The role of sarcopenia and myosteatosis in short- and long-term outcomes following curative-intent surgery for hepatocellular carcinoma in a European cohort. Cancers (Basel). 14:7202022. View Article : Google Scholar : PubMed/NCBI | |
|
Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR and Sawyer MB: Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 47:861–870. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Salman A, Salman M, Moustafa A, Shaaban HE, El-Mikkawy A, Labib S, Youssef A, Omar MG, Matter M and Elkassar H: Impact of sarcopenia on two-year mortality in patients with hcv-associated hepatocellular carcinoma after radiofrequency ablation. J Hepatocell Carcinoma. 8:313–320. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Salman MA, Omar HSE, Mikhail HMS, Tourky M, El-Ghobary M, Elkassar H, Omar MG, Matter M, Elbasiouny AM, Farag AM, et al: Sarcopenia increases 1-year mortality after surgical resection of hepatocellular carcinoma. ANZ J Surg. 90:781–785. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shiba S, Shibuya K, Katoh H, Koyama Y, Okamoto M, Abe T, Ohno T and Nakano T: No deterioration in clinical outcomes of carbon ion radiotherapy for sarcopenia patients with hepatocellular carcinoma. Anticancer Res. 38:3579–3586. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Takagi K, Yagi T, Yoshida R, Shinoura S, Umeda Y, Nobuoka D, Kuise T, Watanabe N and Fujiwara T: Sarcopenia and American society of anesthesiologists physical status in the assessment of outcomes of hepatocellular carcinoma patients undergoing hepatectomy. Acta Med Okayama. 70:363–370. 2016.PubMed/NCBI | |
|
Antonelli G, Gigante E, Iavarone M, Begini P, Sangiovanni A, Iannicelli E, Biondetti P, Pellicelli AM, Miglioresi L, Marchetti P, et al: Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. United European Gastroenterol J. 6:1039–1048. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y, Nishie A and Yamanaka T: Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 100:1523–1530. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, et al: Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy. Oncol Lett. 14:1637–1647. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen BB, Liang PC, Shih TT, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL and Shao YY: Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma. Eur Radiol. 33:512–522. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Naganuma A, Hoshino T, Suzuki Y, Uehara D, Kudo T, Ishihara H, Sato K, Kakizaki S, Yamada M and Takagi H: Association between skeletal muscle depletion and sorafenib treatment in male patients with hepatocellular carcinoma: A retrospective cohort study. Acta Med Okayama. 71:291–299. 2017.PubMed/NCBI | |
|
Mardian Y, Yano Y, Ratnasari N, Choridah L, Wasityastuti W, Setyawan NH and Hayashi Y: ‘Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: A retrospective study’. BMC Gastroenterol. 19:2292019. View Article : Google Scholar : PubMed/NCBI | |
|
Badran H, Elsabaawy MM, Ragab A, Aly RA, Alsebaey A and Sabry A: Baseline sarcopenia is associated with lack of response to therapy, liver decompensation and high mortality in hepatocellular carcinoma patients. Asian Pac J Cancer Prev. 21:3285–3290. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hou GM, Jiang C, Du JP and Yuan KF: Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Cancer Med. 11:317–331. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Imai K, Takai K, Miwa T, Taguchi D, Hanai T, Suetsugu A, Shiraki M and Shimizu M: Rapid depletion of subcutaneous adipose tissue during sorafenib treatment predicts poor survival in patients with hepatocellular carcinoma. Cancers (Basel). 12:17952020. View Article : Google Scholar : PubMed/NCBI | |
|
Endo K, Kuroda H, Kanazawa J, Sato T, Fujiwara Y, Abe T, Sato H, Kooka Y, Oikawa T, Sawara K and Takikawa Y: Impact of grip strength in patients with unresectable hepatocellular carcinoma treated with lenvatinib. Cancers (Basel). 12:21462020. View Article : Google Scholar : PubMed/NCBI | |
|
Choi K, Jang HY, Ahn JM, Hwang SH, Chung JW, Choi YS, Kim JW, Jang ES, Choi GH and Jeong SH: The association of the serum levels of myostatin, follistatin, and interleukin-6 with sarcopenia, and their impacts on survival in patients with hepatocellular carcinoma. Clin Mol Hepatol. 26:492–505. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Harimoto N, Yoshizumi T, Shimokawa M, Sakata K, Kimura K, Itoh S, Ikegami T, Ikeda T, Shirabe K and Maehara Y: Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol Res. 46:1247–1255. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kamachi S, Mizuta T, Otsuka T, Nakashita S, Ide Y, Miyoshi A, Kitahara K, Eguchi Y, Ozaki I and Anzai K: Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatol Res. 46:201–208. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang JX, Yan HT, Ding Y, Liu J, Liu S, Zu QQ and Shi HB: Low psoas-muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization. Ann Med. 54:1562–1569. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yabusaki N, Fujii T, Yamada S, Suzuki K, Sugimoto H, Kanda M, Nakayama G, Koike M, Fujiwara M and Kodera Y: Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection. Int J Surg. 30:136–142. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami T, et al: Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 63:131–140. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Acosta LF, Galuppo R, García CR, Villacorta E, Dugan A, Castellanos AL, Gedaly R and Lee JT: Association between sarcopenia and AFP level in patients undergoing liver transplantation for hepatocellular carcinoma. J Surg Res. 238:10–15. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang J, Chen K, Zheng C, Chen K, Lin J, Meng Q, Chen Z, Deng L, Yu H, Deng T, et al: Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma. J Cachexia Sarcopenia Muscle. 13:2383–2392. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, et al: Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer. 8:92–109. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Uojima H, Chuma M, Tanaka Y, Hidaka H, Nakazawa T, Iwabuchi S, Kobayashi S, Hattori N, Ogushi K, Morimoto M, et al: Skeletal muscle mass influences tolerability and prognosis in hepatocellular carcinoma patients treated with lenvatinib. Liver Cancer. 9:193–206. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Takada H, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Tsuchiya K, Yasui Y, Tamaki N, Takaura K, Komiyama Y, et al: Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma. PLoS One. 13:e01988122018. View Article : Google Scholar : PubMed/NCBI | |
|
Tan Y, Duan T, Li B, Zhang B, Zhu Y, Yan K, Song J, Lv T, Yang J, Jiang L, et al: Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients. Quant Imaging Med Surg. 12:215–228. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Kim N, Yu JI, Park HC, Yoo GS, Choi C, Hong JY, Lim HY, Lee J, Choi MS, Lee JE and Kim K: Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab. Cancer Immunol Immunother. 70:1593–1603. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Iritani S, Imai K, Takai K, Hanai T, Ideta T, Miyazaki T, Suetsugu A, Shiraki M, Shimizu M and Moriwaki H: Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol. 50:323–232. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, Salloum C, Luciani A and Azoulay D: Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma. Ann Surg. 261:1173–1183. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bischoff-Ferrari HA, Orav JE, Kanis JA, Rizzoli R, Schlögl M, Staehelin HB, Willett WC and Dawson-Hughes B: Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 26:2793–2802. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Williams GR, Dunne RF, Giri S, Shachar SS and Caan BJ: Sarcopenia in the older adult with cancer. J Clin Oncol. 39:2068–2078. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Giallauria F, Cittadini A, Smart NA and Vigorito C: Resistance training and sarcopenia. Monaldi Arch Chest Dis. 84:7382016. View Article : Google Scholar : PubMed/NCBI | |
|
Fan J, Kou X, Yang Y and Chen N: MicroRNA-regulated proinflammatory cytokines in sarcopenia. Mediators Inflamm. 2016:14386862016. View Article : Google Scholar : PubMed/NCBI | |
|
Sinclair M, Grossmann M, Angus PW, Hoermann R, Hey P, Scodellaro T and Gow PJ: Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease. J Gastroenterol Hepatol. 31:661–667. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Phillips T and Leeuwenburgh C: Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 19:668–670. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Anderson LJ, Liu H and Garcia JM: Sex differences in muscle wasting. Adv Exp Med Biol. 1043:153–197. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Janssen I, Heymsfield SB, Wang ZM and Ross R: Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol (1985). 89:81–88. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021. View Article : Google Scholar : PubMed/NCBI |
